DRE and LUTS

Principal Investigator

Name
Jonathan Shoag

Institution
NA

Position Title
Resident physician

Email
jes9171@nyp.org

About this CDAS Project

Study
PLCO (Learn more about this study)

Project ID
PLCO-177

Initial CDAS Request Approval
Nov 6, 2015

Title
DRE and LUTS

Summary
Though the digital rectal exam (DRE) is a key component of prostate cancer screening, its utility in the workup of lower urinary tract symptoms is poorly understood. Nocturia is among the most bothersome lower urinary tract symptoms, and its multifactorial etiology requires broad clinical evaluation. Using data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, this study aims to assess the accuracy and reliability of DRE in estimating prostate size and to correlate these findings to the presence of nocturia.

Aims

1. To assess the accuracy and reliability of DRE in estimating prostate size
2. To correlate these findings to the presence of nocturia.

Related Publications

• Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men.
  Stone BV, Shoag J, Halpern JA, Mittal S, Lewicki P, Golombos DM, Bedretdinova D, Chughtai B, Barbieri CE, Lee RK
  BJU Int. 2017 Feb; Volume 119 (Issue 2): Pages 298-304 PUBMED